Results 231 to 240 of about 5,996,360 (285)

Real‐World Outcomes of Mycosis Fungoides and Site‐Specific Nodal Involvement: A Registry‐Based Study of 25 467 Patients

American Journal of Hematology, EarlyView.
ABSTRACT Mycosis fungoides (MF) is a rare extranodal T‐cell lymphoma with primary cutaneous involvement. While it is the most common primary skin lymphoma, large‐scale real‐world data defining survival benchmarks and the prognostic significance of specific nodal sites remain limited.
Charalampos Filippatos, Alexandros Briasoulis, Evangelos Terpos, Despina Fotiou, Maria Gavriatopoulou   +4 more
wiley   +1 more source

ANGPTL3, Apo CIII, Leptin and Triglycerides Are Elevated in Metastatic Prostate Cancer. [PDF]

Cancers (Basel)
Boulay G, Khodr M, Bergeron AC, Wong Chong É, Joncas FH, Castonguay C, Robitaille K, Hovington H, Fradet V, Bergeron A, Pouliot F, Blais J, Seidah NG, Calon F, Gangloff A.   +14 more
europepmc   +1 more source

Biallelic Germline Inactivation of HROB Causes Primary Gonadal Insufficiency and is Potentially Associated with Colonic Polyposis Predisposition

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT The Homologous Recombination Factor With OB‐Fold (HROB) plays a role in homologous recombination and DNA replication, where it enhances the MCM8‐MCM9 helicase complex activity. Recent findings link biallelic germline HROB variants to primary gonadal insufficiency (hypergonadotropic hypogonadism), a phenotype also associated with MCM8/MCM9 ...
Noah C. Helderman, Carli M. Tops, Jelmer Legebeke, Ting Yang, Marcos Díaz Gay, Diantha Terlouw, Lisa E. E. L. O. Lashley, Stefan Aretz, Anna K. Sommer, Mariona Terradas, Laura Valle, Richarda M. de Voer, Ludmil B. Alexandrov, Hans Morreau, Tom van Wezel, Maartje Nielsen   +15 more
wiley   +1 more source

NGF-mediated tumor-stroma crosstalk promotes prostate cancer aggressiveness. [PDF]

J Transl Med
Di Donato M, Giovannelli P, De Sio M, Migliaccio A, Castoria G.   +4 more
europepmc   +1 more source

Liposomal Delivery Systems for Improved Delivery of Docetaxel Against Prostate Cancer. [PDF]

Int J Nanomedicine
Nwabuife JC, Sekhoacha MP.
europepmc   +1 more source

Prognostic impact of spatial niches in prostate cancer. [PDF]

Sci Rep
Schneider F, Böning SH, Antunes BC, Kaczorowski A, Görtz M, Schütz V, Huber J, Stenzinger A, Hohenfellner M, Duensing S, Duensing A.   +10 more
europepmc   +1 more source

Historical Perspective of HER2 Testing and Treatment in Prostate Cancer. [PDF]

Curr Oncol
Zamalloa N, Rose J, Lap CJ, Rajendran R, Estephan F, Jatwani K, Poudel A, Subrahmanyam R, Hurley PJ, Nava VE, Jain M.   +10 more
europepmc   +1 more source

Modern integrative prostate cancer diagnostics. [PDF]

Curr Opin Urol
Grobholz R, Burn F, Prause L.
europepmc   +1 more source